INTERVENE: Indian Trial of Endocardial Ventricular Substrate Ablation to Prevent Recurrent VT Events
Status:
Terminated
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
This study to is being conducted in India to determine the role of catheter-based ablation
for ventricular tachycardia (VT) in post- heart attack patients who meet established
guidelines for implantable cardiodefibrillator (ICD) implantation, but cannot afford it.
These patients would be started on chronic Amiodarone therapy, which has been shown to be
effective but can often lead to multiple side effects.
Patients will therefore be randomized in an even proportion to either a) the control group,
receiving chronic Amiodarone therapy, or the study group, undergoing catheter ablation of VT
in addition to chronic Amiodarone therapy.
This trial will serve as a representative model for the developing world.